Tendencias actuales en el tratamiento del carcinoma broncopulmonar no microcítico localmente avanzado. Tratamientos combinados de quimioterapia y radioterapia

Archivos de Bronconeumologia

Volumn 37, Issue 10, 2001, Pages 435-443

  Cabrera Rodriguez J ^a   Munoz Garcia J ^b   Sanchez de Cos Escuin J ^b  

^a Clinica San Miguel   (Spain)

^b HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; MITOMYCIN; NAVELBINE; PACLITAXEL; VINBLASTINE;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REVIEW;

EID: 0035208390     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(01)75114-9     Document Type: Review

References (51)

1. Radiotherapy alone vs combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
2. Three-dimensional conformal radiation therapy in bronchogenic carcinoma
3. Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small-cell lung cancer
4. Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival
5. Chemotherapy and irradiation in locally advanced squamous cell carcinoma of the uterine cervix
6. A review o neoadjuvant chemotherapy for head and neck cancer: Partially shkrunken tumors may be both leaner and meaner
7. Loss of local control with prolongation in radiotherapy
8. Neoadjuvant cisplatin, metotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
9. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable non-small-cell lung cancer. A meta-analysis
10. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
11. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small-cell lung cancer. A meta-analysis
12. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncolgy Group protocol 91-06
13. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: A 5 year follow-up period
14. Alternating radiotherapy and chemotherapy for inoperable stage III non-small-cell lung cancer: Long-term results of two phase II GOTHA trials
15. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04
16. Final results of phase III trial in regionally advanced unresectable non-small-cell lung cancer
17. Improve survival in stage III non-small-cell lung cancer: 7-Year follow-up of cancer and leukemia group B (CALGB) 8433 trial
18. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. CHART Steering Committee
19. Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG4588
20. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer
21. Hyperfractionated radiation therapy with or without concurrent low dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A radomized study
22. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
23. A randomised phase III trial comparing consolidation treatment with further chemotherapy of chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy
24. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the cancer and leukemia group B and the Eastern Cooperative Oncology Group
25. Multiinstitutional phase II trial of paclitaxel. Carboplatin and concurrent radiation therapy for locally advanced non-small-cell lung cancer
26. Single-agent paclitaxel and radiation for non-small-cell lung cancer
27. Esofagitis in combined modality therapy for locally advanced non-small-cell lung cancer
28. Seven-week continuous infusion paclitaxel concurrent with radiation therapy for locally advanced non-small-cell lung and head and neck cancers
29. Paclitaxel and concurrent radiotherapy in locally advanced non-small-cell lung cancer: The canadian experience
30. Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small-cell lung cancer
31. Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small-cell lung cancer
32. Daily paclitaxel and thoracic radiation therapy for non-small-cell lung cancer: Preliminary results
33. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advaced non-small-cell lung cancer, analysis of early and late pulmonary morbidity
34. Severe lymfocytopenia and intersticial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer
35. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
36. A randomized phase II study of gemcitabine (GEM) or paclitaxel (TXL) or vinorelbine (VNR) as induction chemotherapy (Ind CT) and concomitant chemotherapy (XRT) for unresectable stage III non-small-cell lung cancer (NSCLC). (CALGB study 9431)
37. A phase I/II trial of neoadyuvant chemotherapy with cisplatin and vinorelbine followed by acelerated radiotherapy for patients with inoperable non-small-cell lung carcinoma
38. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage IIIb non-small-cell lung cancer patients
39. Vinorelbine plus cisplatin and concurrent radiotherapy in advanced non-small-cell lung cancer
40. Phase III study of continuous carboplatin over 6 weeks with radistion vs radiation alone in stage III non-small-cell lung cancer (NSCLC)
41. A randomised phase III trial of concurrent carboplatin and twice daily radiotherapy (RT) in locallly advanced non-small-cell lung cancer
42. Pathological stage IIIb non-small-cell lung cancer (NSCLC): Prolonged survival with consolidation docetaxel following concurrent chemoradiotherapy (SWOG 9504)
43. Response, toxivity, failure patterns, and survival in five Radiation Therapy Oncology Groups trials of secuential and/or concurrent chemotheraphy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
44. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced non-small-cell lung carcinoma
45. Toxicities in RTOG combined trials for inoperable non-small-cell lung cancer
46. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small-cell lung cancer: Results of the EORTC 08912 phase I/II study
47. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
48. Assessing the quality of life of patients with cancer
49. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer
50. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma